Webinars


Approaches to Identification and Management of Patients with Increased LDL-C and Lp(a)

Doctor and patient wearing masks, viewing information on a tabletDecember 8, 2021, at 11:00 AM CT

What is the effectiveness of medical therapies that reduce Lp(a) and LDL-C?

Dr. Daniel Rader, Dr. Raul Santos, and moderator Dr. Karol Watson will educate clinicians on the selection of appropriate, effective medical therapies that reduce Lp(a) and LDL-C. They will also describe Machine Learning (ML) components and application in clinical practice. ML algorithms can have high predictive accuracy but may have varied clinical utility. CE/MOC credit available.

Webinar series supported by an education grant from Kaneka Corporation.

Health Equity and Hypertension Treatment

Medical worker checking a woman's blood pressure, both wearing masks

November 30, 2021, at 12:00 PM CT

Presenters: Keith Ferdinand, MD, FACC, FAHA, FASH, FNLA, John M. Flack, MD, MPH, FAHA, FASH, MACP, Karol Watson, MD, PhD
Moderator: Olethia Chisolm, MD

In this informative webinar, experts in the field will discuss healthcare disparities in hypertension treatment and management. Strategies will be presented to reach blood pressure control for all patients. With your help, patients with hypertension will see improved outcomes.

Supported by an education grant from Medtronic.

Join a Webinar Series – Available On-Demand


Square photo of doctor's hand holding stethoscope up to hologram of icons representing human health concerns.

HCM Webinar Series

With your help, patients whose lives have been restricted due to HCM may be able to reduce symptoms and comorbidities. Register today and increase your knowledge of the latest HCM science.


Translucent digital heart representation with grid overlay and red burst of light from one side

ATTR Amyloidosis Webinar Series

Amyloidoses are a heterogeneous group of systemic disorders characterized by extra cellular deposition of a protein-derived material (known as amyloid) that disrupts normal tissue structure and function. Improve the care of patients with Transthyretin Amyloidosis (ATTR amyloidosis) by closing practice and knowledge gaps in disease presentation as experts discuss the complexities of this progressive, degenerative, and multisystemic disorder.


Blood cells illustration

Lipoprotein(a) and LDL-C Webinar Series

Address gaps in your knowledge about Lipoprotein(a) and LDL-C. Watch these evidence-based webinars recognizing the latest science and gain expert insights into incorporating the measurement of Lp(a) into patient evaluation and risk assessment. CE/MOC available.

Webinar series supported by an education grant from Kaneka Corporation.


Posterior Circulation Stroke Webinar Series

Stylized drawing of human brain superimposed over layers of bone, skin, nerves, etc.

Timely recognition of the signs and symptoms of posterior circulation stroke (PCS) is critical for properly diagnosing PCS, understanding the clinical course, and managing patients with acute PCS diagnosis. Delayed or incorrect diagnosis results in inadequate acute care and poorer outcomes. While PCS can be challenging to recognize; in this webinar series learn to distinguish characteristic clinical patterns and apply AHA/ACC guideline recommendations.

Enduring Webinars

Secondary Stroke Prevention: Evidence-based Recommendations

Patient listening to doctor explain medical advice

Join Drs. Broderick, Kleindorfer, and Towfighi as they identify the implications for clinicians in the 2021 Guideline for the Prevention of Stroke in Patients with Stroke and Transient Ischemic Attack. With your help through prevention strategies, patients with ischemic stroke/transient ischemic attack may experience improved outcomes and quality of life.

Joseph P. Broderick, MD, FAHA

Moderator: Joseph P. Broderick, MD, FAHA
Professor of Neurology and Rehabilitation Medicine, University of Cincinnati College of Medicine
Director, University of Cincinnati Gardner Neuroscience Institute

Dawn Kleindorfer, MD, FAHA

Presenter: Dawn Kleindorfer, MD, FAHA
Writing Group Chair
Chair and Professor of Neurology, University of Michigan

Amytis Towfighi, MD, FAHA

Presenter: Amytis Towfighi, MD, FAHA
Writing Group Vice Chair
Chief of Neurology, Associate Medical Director of Neurological Services, and Director of Research, LAC+USC Medical Center
Director, Neurological Services, Los Angeles County Department of Health Services
Associate Professor of Neurology (Clinical Scholar), USC Keck School of Medicine
Co-Director of Research and Director of Implementation Science, SC Clinical and Translational Science Institute

Ethics and Professionalism: A Common Ground of Understanding

5 x 5 grid of health professionals

Ethics and professionalism in science and medicine are central in addressing contemporary issues. In this current climate how are we to respond to unprecedented public challenges, including the physical and economic health of the country, tragedies of social justice, and a divisive political climate?

Join former AHA Presidents Dr. Bob Harrington and Dr. Ivor Benjamin along with other thought leaders for an engaging roundtable conversation in regards to the 2021 AHA/ACC Ethics and Professionalism Report.

Building on the AHA’s long history of leadership in the areas of medical ethics and professionalism, this roundtable discussion will include reflections on specific issues such as:

  • shared clinical decision-making
  • the relationship of clinicians with patients, other clinicians, and organizations
  • allocation of resources
  • scientific responsibility and integrity in research

Bob Harrington Ivor Benjamin
Dr. Bob Harrington Dr. Ivor Benjamin

Black anatomical heart drawing in a green circleKey Implications for Clinicians in the 2020 AHA/ACC Guideline for the Management of Patients with Valvular Heart Disease

In your evaluation of a patients with suspected valvular heart disease, learn the diagnostic strategies for early detection of valvular disease and appropriate long term management. Discover appropriate tools for assessment and intervention based on valvular disease stage, specifically in cases of mitral regurgitation and aortic stenosis.

These are some of the areas identified in the new guideline on managing patients with valvular heart disease. Thoralf Sundt, MD, Vera Rigolin, MD, and Hani Jneid, MD explore guideline updates and explain how revised recommendations translate into clinical practice.